SpyGlass Pharma has filed a notice of an exempt offering of securities to raise $90,019,986.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, SpyGlass Pharma is raising $90,019,986.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Patrick Mooney played a key role…